Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-18, Stock:PFE, The news for the past five days is as follows:
2018-09-11: NEWS1: Pfizer Announces Results for JAVELIN Renal 101 Study.NEWS2: Pfizer to Idle Plants in North Carolina With Hurricane Florence Approaching.NEWS3: 3 Small Biotech Stocks That Almost Doubled in Past Month.NEWS4: 3 Small Biotech Stocks That Almost Doubled in Past Month.NEWS5: Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer.NEWS6: Merck, Pfizer Report Positive Top-line Results From Phase III JAVELIN 101 Study.NEWS7: Merck, Pfizer Report Positive Top-line Results From Phase III JAVELIN 101 Study.
2018-09-12: NEWS1: How Companies Are Getting Ready for Hurricane Florence.NEWS2: Pfizer's Drug Combo Betters Survival in Kidney Cancer Study.NEWS3: Pfizer's Drug Combo Betters Survival in Kidney Cancer Study.NEWS4: Dow Movers: INTC, CVX.NEWS5: Dow Movers: INTC, CVX.NEWS6: The Outlook for AstraZeneca Is Positive, But It’s Too Early to Pull the Trigger.NEWS7: Exact Sciences Posted 52.2% Returns in the Last Month.NEWS8: Pfizer&apos;s Drug Combo Betters Survival in Kidney Cancer Study.
2018-09-13: NEWS1: Sangamo Therapeutics: The Promise of Zinc Fingers.NEWS2: PJP, PFE, MRK, LLY: ETF Outflow Alert.NEWS3: PJP, PFE, MRK, LLY: ETF Outflow Alert.NEWS4: 3 Lung Cancer Stocks That Could End September on a High Note.NEWS5: 3 Lung Cancer Stocks That Could End September on a High Note.NEWS6: JNJ Stock Up 7% in the Past Month: What Drove the Bulls?.NEWS7: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 14, 2018.NEWS8: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 14, 2018.NEWS9: Johnson & Johnson: Analyst Recommendations and Target Price.NEWS10: See what the IHS Markit Score report has to say about Pfizer Inc..
2018-09-14: NEWS1: Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know.NEWS2: Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know.NEWS3: Wall Street Analysts Are Mostly Positive on Merck in September.NEWS4: Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know.NEWS5: Week Ahead In Pharmaceuticals: 7 Stocks To Watch (CMRX, VRNA, NITE...).NEWS6: Week Ahead In Pharmaceuticals: 7 Stocks To Watch (CMRX, VRNA, NITE...).NEWS7: How Spark Therapeutics Is Positioned in 2018.NEWS8: Pharma/Biotech Stocks to Watch This Prostate Cancer Month.NEWS9: Pharma/Biotech Stocks to Watch This Prostate Cancer Month.NEWS10: Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus.NEWS11: Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus.NEWS12: Pharma Stock Roundup: AZN&apos;s Leukemia Drug Wins FDA Nod, MRK&apos;s Keytruda in Focus.NEWS13: Dow 30 Stock Roundup: Apple Unveils 3 New iPhones, Boeing Clinches $2.9B Deal.NEWS14: Dow 30 Stock Roundup: Apple Unveils 3 New iPhones, Boeing Clinches $2.9B Deal.NEWS15: Pharma/Biotech Stocks to Watch This Prostate Cancer Month.NEWS16: Pre-Market Most Active for Sep 14, 2018 :  NIO, NI, CRON, AAPL, TLRY, SHPG, AZN, CGC, ABB, PFE, QQQ, MU.NEWS17: Pre-Market Most Active for Sep 14, 2018 :  NIO, NI, CRON, AAPL, TLRY, SHPG, AZN, CGC, ABB, PFE, QQQ, MU.NEWS18: A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis.NEWS19: A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis.NEWS20: Dow 30 Stock Roundup: Apple Unveils 3 New iPhones, Boeing Clinches $2.9B Deal.NEWS21: A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis.NEWS22: ViiV Files Application To EMA For Two-drug Regimen To Treat HIV - Quick Facts.NEWS23: ViiV Files Application To EMA For Two-drug Regimen To Treat HIV - Quick Facts.
2018-09-17: NEWS1: Pfizer&apos;s Skin Disease Candidates Positive in Mid-Stage Study.NEWS2: A Look at the Market Caps of the Pharma Stocks under Review.NEWS3: How Pharmaceutical ETFs Have Performed in 2018.NEWS4: USMV, ONLN: Big ETF Inflows.NEWS5: USMV, ONLN: Big ETF Inflows.NEWS6: These Pharmaceutical Stocks Have Surpassed the S&P 500 in 2018.NEWS7: This cancer-fighting biotech sped from startup to IPO filing in 10 months.NEWS8: Keytruda Could Boost Merck’s Revenue Growth in 2018 and Beyond.NEWS9: Atomwise Enters Evaluation Agreement With Pfizer - Quick Facts.NEWS10: Atomwise Enters Evaluation Agreement With Pfizer - Quick Facts.

Answer: Rise